Table 3 The comparison of embryo transfer cycles outcome between two groups
Variable | L-carnitine group n = 47 | Placebo group n = 50 | p-value* |
|---|---|---|---|
The number of cases that have not referred for frozen embryo transfer until the time of data analysis | 5 (10.6%) | 3 (6%) | 0.65 |
No. of transferred embryos in fresh cycles | 2.1 (0.37) | 2.2 (0.44) | 0.71 |
No. of transferred embryos in FET cycles | 2.0 (0.27) | 2.0 (0.37) | 0.38 |
Implantation rate in fresh ET cycle (mean ± SE) | 0.25 (0.25) | 0.26 (0.11) | 0.95 |
Clinical pregnancy rate/ fresh ET | 1/7 (14.3%) | 3/9 (33.3%) | 0.58 |
Ongoing pregnancy rate/fresh ET | 1/7 (14.3%) | 2/9 (22.2%) | 0.68 |
Implantation rate in FET cycle | 0.54 (0.35) | 0.52 (0.27) | 0.89 |
The clinical pregnancy rate /FET cycle | 17 /35 (48.5%) | 20 /38 (52.6%) | 0.71 |
The ongoing pregnancy rate/ FET cycle | 15 / 35 (42.8%) | 19 / 38 (50.0%) | 0.70 |
Cumulative ongoing pregnancy rate/total ET cycles | 16 /42 (43.2%) | 21/ 47 (56.8%) | 0.67 |